News

Raleigh, N.C. – September 24, 2026 -- Cardinal Infrastructure Group Inc. (Nasdaq: CDNL) has expanded its total credit facility commitments to $550 million after its subsidiary, Cardinal Civil Contracting, LLC, signed a second amendment to its senior secured credit agreement.

New $250 million delayed draw term loan targets acquisitions

The amendment adds a delayed draw term loan facility of up to $250 million, which the company can access in as many as five separate advances over 18 months through March 2028. Cardinal intends to use the proceeds to finance permitted acquisitions and related fees and expenses. The facility remained undrawn at the completion of syndication.

Pune – September 24, 2026 -- The global autoimmune treatment market reached USD 176.6 billion in 2025 and is forecast to expand at a 6.9% CAGR through 2034, hitting USD 321.95 billion, according to a new analysis from Maximize Market Research.

North America dominates the market on strong pharmaceutical R&D infrastructure

North America held the largest share of the market in 2025, driven by high disease prevalence, advanced healthcare infrastructure, established specialist care and elevated healthcare spending. The United States anchors regional growth, backed by leading pharmaceutical and biotechnology firms, advanced diagnostic capacity, and rising adoption of biologics, immunosuppressants, monoclonal antibodies and targeted therapies. Canada and Mexico are contributing through improving healthcare access and disease awareness.

Pune, India – September 24, 2026 -- The global nanomedicine market reached USD 207.91 billion in 2025 and is projected to hit USD 581.2 billion by 2034, expanding at a 12.1% compound annual growth rate, according to a new report from Maximize Market Research.

North America commands the largest share on pharmaceutical R&D strength

North America held the largest share of the market in 2025, driven by advanced healthcare infrastructure, deep pharmaceutical and biotechnology research pipelines, and high healthcare expenditure. The United States anchors regional growth through its established research ecosystem and rising adoption of nanotechnology-based drug delivery, diagnostics and precision medicine platforms. Canada and Mexico are contributing through expanding healthcare capabilities and research initiatives.

San Francisco – September 24, 2026 -- The U.S. Bankruptcy Court for the District of New Jersey approved HouseCanary's first-day motions, granting the property intelligence provider access to debtor-in-possession financing and clearing the way for uninterrupted operations during its Chapter 11 reorganization.

Court clears customer, employee and financing relief on first-day hearing

The approved motions cover continuation of customer programs, employee obligations and ordinary-course business operations, alongside debtor-in-possession financing to bolster liquidity. A further hearing is scheduled for October to consider additional debtor-in-possession financing for the company.

Bogotá – September 24, 2026 -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) named Joaquín Gutiérrez Caballero as permanent Chief Executive Officer, effective September 28, 2026, following a unanimous board vote.

Board replaces interim leadership with unanimous vote

The appointment ends the interim tenure of Camilo Barco, who steps down as CEO effective September 27, 2026. All members of Ecopetrol's Board of Directors participated in the vote, which followed a selection process run by the Board's Compensation, Nomination and Culture Committee under the company's Succession Policy.

Incoming CEO brings 30 years of cross-sector experience

Gutiérrez Caballero holds a degree in Business Administration and postgraduate specializations in Telecommunications Project Management, Telecommunications Law, and Healthcare Services Management. He has more than 30 years of professional experience, according to the company.

Easton, PA – September 24, 2026 -- A structured construction management workflow is reducing cost overruns and schedule delays on market-rate residential projects, according to a new HelloNation article featuring insights from Construction Management Expert Jovana Villanueva of Easton, PA.

Pre-construction planning cuts change orders before ground is broken

The article details how early cost modeling, material availability checks, and constructability reviews of architectural drawings identify design conflicts before construction starts. This upfront analysis is presented as the primary lever developers have to reduce change orders and keep projects aligned with financial targets from day one.

St. Petersburg – September 24, 2026 -- ARK Investment Management LLC has launched the ARK Active Autocallable Income ETF (ARKY), targeting a 17.5% coupon by applying a volatility-harvesting strategy to its disruptive-innovation equity universe. The fund began trading on the Cboe BZX Exchange, marking ARK's first entry into the income-strategy category.

ARKY diversifies risk across 25 to 50 single-stock autocallable positions

Each holding in the portfolio references a single stock from ARK's high-conviction innovation universe and carries a 50% to 60% coupon barrier. A breach in one underlying asset affects only that position, while the remaining portfolio can continue generating income, according to the company.

Pune, India – September 24, 2026 -- The global multiple sclerosis treatment market reached USD 26.76 billion in 2025 and is forecast to climb to USD 44.45 billion by 2034, expanding at a 5.8% CAGR, according to a new report from Maximize Market Research.

Disease-modifying therapies and biologics drive current market expansion

Rising MS prevalence, improved diagnostic capabilities, and growing adoption of immunomodulators, immunosuppressants, interferons, oral disease-modifying therapies (DMTs), and monoclonal antibodies are fueling demand across relapsing-remitting (RRMS), primary progressive (PPMS), secondary progressive (SPMS), and clinically isolated syndrome (CIS) patient segments. High-efficacy biologics and oral treatment options are increasingly displacing older therapy classes as patients and physicians prioritize convenience and disease-progression control.

Pune, India – September 24, 2026 -- The global placenta market is set to nearly triple from USD 96.1 billion in 2025 to USD 275.18 billion by 2034, expanding at a 12.4% compound annual growth rate, according to a new analysis by Maximize Market Research.

Asia-Pacific leads global demand as Japan, South Korea and China drive placenta research

Asia-Pacific held the leading market position in 2025, backed by strong placenta research and development in Japan, South Korea and China, alongside rising production of placenta-derived products for pharmaceutical and cosmetics applications. The region's large consumer base and appetite for anti-aging and skincare solutions continue to underpin its dominant position.

Austin, Texas – September 24, 2026 -- Forge AI Deployment has committed $30 million to webAI to build and deploy private, specialized AI systems for enterprise customers, the companies announced.

Forge pairs $30 million commitment with webAI's collaborative intelligence platform

The deal combines webAI's technology with Forge's enterprise deployment and services operation. Forge will work directly with customers to build AI systems around proprietary data, workflows and operations, running on infrastructure those customers control, from individual specialized AI Personas to company-wide deployments.